Results 61 to 70 of about 44,275 (251)

Application Value of Myocardial Extracellular Volume in Preoperative Assessment of TAVI

CT Lilun yu yingyong yanjiu
Objective: To explore the value of myocardial extracellular volume (ECV) measured using dual-energy computed tomography (CT) in preoperative risk stratification for transcatheter aortic valve implantation (TAVI).
Kaige ZHANG, Chunxia WANG, Duo GAO, Kailiang FU   +3 more
doaj   +1 more source

Maternal and Neonatal Outcomes after Attempted External Cephalic Version among Women with One Previous Cesarean Delivery

American Journal of Perinatology Reports, 2018
Objective This study was aimed to evaluate success rates of (1) external cephalic version (ECV) among women with one prior cesarean delivery (CD) and (2) maternal and neonatal outcomes after ECV among women with prior CD.
Rodney A. McLaren Jr., Fouad Atallah, Nelli Fisher, Howard Minkoff   +3 more
doaj   +1 more source

On the global well-posedness of the critical quasi-geostrophic equation

, 2007
We prove the global well-posedness of the critical dissipative quasi-geostrophic equation for large initial data belonging to the critical Besov space $\dot B^0_{\infty,1}(\RR^2).
Abidi, Hamadi, Hmidi, Taoufik
core   +4 more sources

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Extracellular volume and left ventricular hypertrophy by cardiac magnetic resonance are independent predictors of cardiovascular outcome in obesity

Scientific Reports, 2022
This retrospective cohort study investigated for association between increased extracellular volume (ECV) and left ventricular hypertrophy (LVH) by cardiac magnetic resonance (CMR) and cardiovascular composite outcomes in obesity.
Panuwat Lertlaksameewilai, Thammarak Songsangjinda, Yodying Kaolawanich, Ahthit Yindeengam, Rungroj Krittayaphong   +4 more
doaj   +1 more source

The Iowa Perinatal Letter, January-February-March 2007, Vol. 28, no.1 [PDF]

, 2007
This newsletter from The Department of Public Health about perinatal health care and ...

core  

Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography [PDF]

, 2018
PURPOSE OF REVIEW: This review article discusses the evolution of extracellular volume (ECV) quantification using both cardiovascular magnetic resonance (CMR) and computed tomography (CT).
Bastarrika, G, Moon, JC, Scully, PR, Treibel, TA   +3 more
core   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Development and Validation of Imaging‐Free Myocardial Fibrosis Prediction Models, Association with Outcomes, and Sample Size Estimation for Phase 3 Trials

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Phase 3 trials testing whether pharmacologic interventions targeting myocardial fibrosis improve outcomes require myocardial fibrosis measurement that does not rely on tomographic imaging with intravenous contrast.
Nicholas Black, Joshua Bradley, Gavin Lewis, Jakub Lagan, Christopher Orsborne, Fardad Soltani, John P. Farrant, Theresa McDonagh, Matthias Schmitt, João L. Cavalcante, Martin Ugander, Javed Butler, Mark C. Petrie, Christopher A. Miller, Erik B. Schelbert   +14 more
doaj   +1 more source

Half-Dose versus Single-Dose Gadobutrol for Extracellular Volume Measurements in Cardiac Magnetic Resonance

Journal of Cardiovascular Development and Disease, 2023
Background: Cardiac magnetic resonance (CMR) imaging with gadolinium-based contrast agents offers unique non-invasive insights into cardiac tissue composition.
Patrick Doeblin, Fridolin Steinbeis, Martin Witzenrath, Djawid Hashemi, Wensu Chen, Karl Jakob Weiss, Philipp Stawowy, Sebastian Kelle   +7 more
doaj   +1 more source